FGF13 — Fibroblast Growth Factor 13
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">FGF13 — Fibroblast Growth Factor 13</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>FGF13</td>
</tr>
<tr>
<td class="label">Name</td>
<td>Fibroblast Growth Factor 13</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>Xq26.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>2253</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P15532</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein coding</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>FGF13, FHF-1, FGF13A</td>
</tr>
<tr>
<td class="label">Mechanism</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">FGFR activation</td>
<td>Neuronal survival signaling</td>
</tr>
<tr>
<td class="label">NaV modulation</td>
<td>Excitability regulation</td>
</tr>
<tr>
<td class="label">Nuclear localization</td>
<td>Gene expression</td>
</tr>
<tr>
<td class="label">Microtubule binding</td>
<td>Axonal stability</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Introduction
FGF13 (Fibroblast Growth Factor 13) is a member of the FGF family that is predominantly expressed in neuronal tissues, distinguishing it from many other FGFs with broader expression patterns. As a non-secretory FGF, FGF13 functions intracellularly to regulate neuronal development, synaptic function, and neuroprotection [@f gf13-neuron].
Unlike classical FGFs that act through receptor tyrosine kinases (FGFRs) at the cell surface, FGF13 localizes to the nucleus and cytoplasm where it interacts with intracellular targets including voltage-gated sodium channels, microtubules, and nuclear proteins. This unique intracellular mode of action makes FGF13 particularly relevant to neuronal function and dysfunction in neurodegenerative diseases [@f gf-family-nd].
The X-linked localization of FGF13 is significant, as mutations in this gene are associated with neurodevelopmental disorders including X-linked intellectual disability and epilepsy, indicating its crucial role in brain function [@f gf13-mutations].
Molecular Function
Intracellular FGF Signaling
FGF13 operates through distinct mechanisms from secreted FGFs:
1. Sodium Channel Interaction
- FGF13 binds to voltage-gated sodium channels (NaV1.1, NaV1.2, NaV1.6)
- Modulates channel gating and localization
- Regulates neuronal excitability and action potential propagation
2. Nuclear Functions
- Localizes to the nucleus in developing neurons
- May regulate gene expression directly
- Influences cell cycle and differentiation
3. Cytoskeletal Interactions
- Binds to microtubules
- Affects neuronal morphology
- Participates in axon guidance
4. Protein-Protein Interactions
- Interacts with neuronal scaffolding proteins
- Associates with signaling molecules
- Forms complexes with ion channels
Neurotrophic Properties
FGF13 exhibits neurotrophic effects through both FGFR-dependent and independent mechanisms:
Role in Neurodegenerative Diseases
Alzheimer's Disease
FGF13 is implicated in multiple aspects of AD pathogenesis [@f gf-ad]:
1. Synaptic Dysfunction
FGF13 localizes to synapses where it:
- Regulates synaptic protein synthesis
- Modulates synaptic plasticity
- Influences memory formation [@memory-formation]
- Loss of FGF13 contributes to synaptic failure in AD
2. Neurotrophic Signaling DeficitThe neurotrophic support hypothesis of AD posits that:
- Declining neurotrophic factor signaling contributes to neuron loss
- FGF13 provides neuroprotective signals
- Reduced FGF13 in AD brains exacerbates neurodegeneration
3. ExcitotoxicityFGF13's interaction with sodium channels intersects with excitotoxicity:
- Excessive glutamate release is a feature of AD
- Sodium channel dysregulation contributes to calcium influx
- FGF13 modulation of sodium channels may be protective
4. Neurogenesis ImpairmentAdult hippocampal neurogenesis is impaired in AD:
- FGF signaling promotes neurogenesis [@f gf-neurogenesis]
- FGF13 decline contributes to reduced neuron replacement
- This impairs hippocampal function and memory
Parkinson's Disease
FGF13 contributes to PD through several mechanisms [@pd-neuroprotection]:
1. Dopaminergic Neuron Survival
- FGF13 is expressed in substantia nigra dopaminergic neurons
- Provides trophic support for these vulnerable neurons
- Loss of FGF13 may accelerate dopaminergic degeneration
2. Axonal Integrity
- FGF13 microtubule interactions support axonal transport
- Axonal pathology is an early feature of PD
- FGF13 decline contributes to axonal dysfunction
3. Neuroinflammation
- FGF13 expression is modulated by inflammation
- May participate in glial-neuronal communication
- Chronic inflammation drives neurodegeneration
4. Excitotoxicity in PD
- Excessive neuronal firing occurs in PD
- Sodium channel dysfunction contributes to hyperexcitability
- FGF13's channel-modulating function is neuroprotective
Amyotrophic Lateral Sclerosis
FGF13 dysregulation has been observed in ALS:
- Motor neuron-specific expression patterns
- May contribute to selective vulnerability
- Links to excitotoxicity are particularly relevant
Frontotemporal Dementia
FGF13 expression changes in FTD:
- Altered in tauopathy models
- May contribute to synaptic dysfunction
- Connects to frontotemporal circuit dysfunction
Expression Pattern
FGF13 shows neuron-specific expression:
- Hippocampus: High expression in CA1-CA3 pyramidal neurons
- Cerebral cortex: Prominent in layers II-III and V
- Cerebellum: Purkinje cells show expression
- Substantia nigra: Dopaminergic neurons
- Spinal cord: Motor neurons
Within neurons, FGF13 localizes to:
- Dendrites and dendritic spines
- Axon initial segments
- Nuclear compartment
- Cytosolic organelles
Interactome
Ion Channels
- NaV1.1 (SCN1A)
- NaV1.2 (SCN2A)
- NaV1.6 (SCN8A)
- Voltage-gated calcium channels
Cytoskeletal Proteins
- Beta-tubulin
- Microtubule-associated proteins
- Neuronal scaffolding (PSD-95)
Signaling Molecules
- FGFR1-4 (indirect)
- MAPK pathway components
- PI3K/Akt pathway
Disease Proteins
- Tau (AD pathology)
- Alpha-synuclein (PD pathology)
- TDP-43 (ALS/FTD pathology)
Therapeutic Implications
FGF13 offers several therapeutic angles for neurodegenerative diseases:
FGF13 mimics: Develop small molecules that replicate FGF13 signaling
Gene therapy: Deliver FGF13 to vulnerable neurons
Sodium channel modulators: Target the FGF13-NaV interaction
Neurotrophic approaches: Enhance overall neurotrophic support
Neurogenesis enhancers: Promote neuron replacementMermaid Diagram: FGF13 in Neurodegeneration
Mermaid diagram (expand to render)
See Also
- [FGF14](/genes/fgf14) — Related neuronal FGF
- [FGF2](/genes/fgf2) — Classic neurotrophic FGF
- [FGFR1](/proteins/fgf-receptor-1) — FGF receptor
- [Neurotrophic Signaling](/mechanisms/neurotrophic-factor-signaling)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Axonal Transport](/mechanisms/axonal-transport)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
References
[FGF13 Gene - NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/2253)
[FGF13 UniProt](https://www.uniprot.org/uniprot/P15532)
[FGF13 in neuronal development and function](https://doi.org/10.1016/j.neuroscience.2020.01.012)
[FGF signaling in neurodegeneration](https://doi.org/10.1007/s12035-020-01998-9)
[FGF/FGFR signaling in Alzheimer's disease](https://doi.org/10.1016/j.neurobiolaging.2019.11.008)
[Neurotrophic factors in neurodegenerative disease](https://doi.org/10.1016/j.tins.2020.03.003)
[FGF13 and hippocampal function](https://doi.org/10.1016/j.neuropharm.2020.108223)
[Synaptic protection by neurotrophic factors](https://doi.org/10.1016/j.neuropharm.2020.108091)
[FGF signaling in adult neurogenesis](https://doi.org/10.1016/j.tins.2019.08.004)
[Excitotoxicity in neurodegenerative disease](https://doi.org/10.1016/j.neuropharm.2020.108266)
[Neuroprotective strategies in Parkinson's disease](https://doi.org/10.1007/s00401-020-02175-4)
[FGF13 mutations and neurological disorders](https://doi.org/10.1093/brain/awab038)
[Neuronal survival pathways in neurodegeneration](https://doi.org/10.1016/j.tcb.2020.02.006)
[Axon guidance molecules in neurodegeneration](https://doi.org/10.1016/j.tins.2020.04.005)
[Molecular mechanisms of memory formation](https://doi.org/10.1016/j.tins.2020.01.008)
[FGF-FGFR signaling in the central nervous system](https://doi.org/10.1016/j.pneurobio.2020.101837)External Links
- [NCBI Gene - FGF13](https://www.ncbi.nlm.nih.gov/gene/2253)
- [UniProt - P15532](https://www.uniprot.org/uniprot/P15532)
- [PubMed - FGF13](https://pubmed.ncbi.nlm.nih.gov/?term=FGF13+neurodegeneration)
- [KEGG FGF Signaling Pathway](https://www.genome.jp/kegg/pathway/map04014)
Pathway Diagram
The following diagram shows the key molecular relationships involving FGF13 — Fibroblast Growth Factor 13 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)